Shilpa Medicare Ltd

SHILPAMED NSE Healthcare Pharmaceuticals
Microcap 250
₹959.05
+2.04%
Delayed · cached 15 min

Fair value analysis

SHILPAMED
Shilpa Medicare Ltd
Healthcare›Pharmaceuticals
₹939.90
Close used for this calculation
₹300.69Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
32/100
Profitability17/25
Returns2/25
Balance Sheet11/25
Efficiency2/25
Growth3/25
Weak
Quality radar
32Prof.17/25Ret.2/25Eff.2/25B.Sht11/25Growth3/25

Consensus fair value

₹300.69
Above FV
▼ -68.0% against the close used
Model range ₹80.86 – ₹444.11
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹80.86Fair value₹300.69Bull₹444.11
FairClose
52-week traded range
52W low ₹267.0052W high ₹964.15

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Shilpa Medicare Ltd closed at ₹939.90, 212.6% above the consensus fair value of ₹300.69 drawn from 9 valuation models.

Financial DNA score 32/100 — Weak. P/E of 66.1x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹213.90
-77.2%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=6.5%, r=10%, tg=3%, n=10yr
Graham Number
₹205.49
-78.1%
√(22.5 × EPS × BVPS)
EPS=12.44, BVPS=150.87 · outside Graham range (P/E 66.1, P/B 6.2) — asset-light, treat as a rough floor
Graham Formula
₹248.36
-73.6%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=6.5%, FD=7%
P/E Fair Value
₹444.11
-52.7%
EPS × 35.7x (sector P/E)
EPS=12.44, Sector P/E=35.7x
Peter Lynch (PEG)
₹80.86
-91.4%
EPS × Growth% (PEG = 1 is fair)
EPS=12.44, g=6.5%
EV/EBITDA
₹334.69
-64.4%
(EBITDA × 13.3x − Net Debt) ÷ Shares
EBITDA=5.55B
Book Value (P/B)
₹112.77
-88.0%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=150.87, ROE=9%, g=6%, r=10%
Reverse DCF
₹939.90
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 25.2% | Historical: 6.5%
Margin of Safety
₹208.47
-77.8%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=277.97, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.